HIV Integration Targeting: A Pathway Involving Transportin-3 and the Nuclear Pore Protein RanBP2
Open accessThe DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
Genome-wide siRNA screens have identified host cell factors important for efficient HIV infection, among which are nuclear pore proteins such as RanBP2/Nup358 and the karyopherin Transportin-3/TNPO3. Analysis of the roles of these proteins in the HIV replication cycle suggested that correct trafficking through the pore may facilitate the subsequent integration step. Here we present data for coupling between these steps by demonstrating that depletion of Transportin-3 or RanBP2 altered the terminal step in early HIV replication, the selection of chromosomal sites for integration. We found that depletion of Transportin-3 and RanBP2 altered integration targeting for HIV. These knockdowns reduced HIV integration frequency in gene-dense regions and near gene-associated features, a pattern that differed from that reported for depletion of the HIV integrase binding cofactor Psip1/Ledgf/p75. MLV integration was not affected by the Transportin-3 knockdown. Using siRNA knockdowns and integration targeting analysis, we also implicated several additional nuclear proteins in proper target site selection. To map viral determinants of integration targeting, we analyzed a chimeric HIV derivative containing MLV gag, and found that the gag replacement phenocopied the Transportin-3 and RanBP2 knockdowns. Thus, our data support a model in which Gag-dependent engagement of the proper transport and nuclear pore machinery mediate trafficking of HIV complexes to sites of integration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Effects of Transportin-3 and RanBP2 depletion on integration near multiple chromosomal features. Genes targeted by siRNA in infected cells including the control, GL2, are shown above the columns. Mock cells received no siRNA. The genomic features analyzed are shown in the rows and labeled on the left. Relationships between integration frequency and feature density are summarized using ROC curve areas [18], where increasing shades of blue indicate a negative correlation with integration frequency and increasing shades of red indicate a positive correlation with integration frequency relative to matched random control distributions. The control GL2 siRNA set was used for pairwise statistical comparisons (overlay dashes). P values summarizing the significance of the departure from the GL2 control are shown with asterisks (*P<0.05; **P<0.01; ***P<0.001). Note that the asterisks and the heat map summarize different comparisons (to siGL2 and matched random controls, respectively). The base pair values in the row labels indicate the size of the genomic interval used for analysis–often the most appropriate interval is not known, so several different interval sizes are compared. A more detailed guide to the data presented in this figure can be found in Text S1. An interactive version of this figure is available as Figure S5.](https://figures.cochat.ai/paper-figures/b86a468bc0314fbf9ec12b4991cdda2b/hiv-integration-targeting-a-pathway-involving-transportin-3-and-the-nuclear-pore-figure-2.jpg)






![Figure 9 Model for coupling of nuclear import and integration targeting. Interaction with Transportin-3 and RanBP2 shuttles the PIC through the nuclear pore and toward gene dense regions favored for HIV integration. Interactions with additional factors in the nucleus (ANAPC2, WDH1, IK, PRPF38A, and SNW1) may also play a role in site selection upstream of the known integration cofactor Ledgf/p75, which targets integration to active transcription units. RNA Pol indicates RNA polymerase II, which is known to be required for transcriptional activity, and which promotes integration [13]–[15], [18]. Nucleosomes are shown because target DNA is known to be wrapped in nucleosomes during the integration step [36], [57]–[60]. PIC, preintegration complex; FG, phenylalanine-glycine repeat sequences of nuclear pore proteins.](https://figures.cochat.ai/paper-figures/8bfb1b515cab48e1acda8e401d271b5e/hiv-integration-targeting-a-pathway-involving-transportin-3-and-the-nuclear-pore-figure-9.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Depletion of cellular Nup153 or Nup358 also shifted HIV-1 integration away from gene-dense regions of chromatin88,89”
From Structure and function of retroviral integrase (2022) · cites this paper as [89]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Initial sequencing and analysis of the human genome
International Human Genome Sequencing Consortium, Whitehead Institute for Biomedical Research, C. F. G. R., Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., et al. (2001) · Nature · doi:10.1038/35057062 · Cited by 24,216
The sequence of the human genome
Venter, J. C., Adams, M. D., Myers, E. W., Li, P. W., Mural, R. J., Sutton, G. G., Smith, H. O., Yandell, M., Evans, C. A., Holt, R. A., et al. (2001) · Science · doi:10.1126/science.1058040 · Cited by 13,909
In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
Naldini, L., Blömer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F. H., Verma, I. M., & Trono, D. (1996) · Science · doi:10.1126/science.272.5259.263 · Cited by 4,903 · cited 1×
“VSV-G pseudotyped HIV vector particles were produced in HEK 293T cells by Lipofectamine (Invitrogen, Carlsbad CA) transfection of p156RRLsin-PPTCMVGFPWPRE [52], the packaging construct pCMVdeltaR9 [53], and the vesicular stomatitis virus G-producing plasmid pMD.”
MethodHIV-1 Integration in the Human Genome Favors Active Genes and Local Hotspots
Schröder, A. R. W., Shinn, P., Chen, H., Berry, C., Ecker, J. R., & Bushman, F. (2002) · Cell · doi:10.1016/s0092-8674(02)00864-4 · Cited by 1,832
Self-citationIdentification of host proteins required for HIV infection through a functional genomic screen
Brass, A. L., Dykxhoorn, D. M., Benita, Y., Yan, N., Engelman, A., Xavier, R. J., Lieberman, J., & Elledge, S. J. (2008) · Science · doi:10.1126/science.1152725 · Cited by 1,449 · cited 1×
“Passage through the pore is likely a preferred route of nuclear entry for HIV-1 even in dividing cells – several components of the nuclear pore are required for efficient infection of dividing cells, even though PICs might access the nucleus during nuclear breakdown in mitosis”
BackgroundSimonis, M., Klous, P., Splinter, E., Moshkin, Y., Willemsen, R., de Wit, E., van Steensel, B., & de Laat, W. (2006) · Nature Genetics · doi:10.1038/ng1896 · Cited by 1,386 · cited 1×
“Several studies suggest that chromosomes and genes are nonrandomly distributed in the nucleus, though the organization is not fully clarified [42–44].”
BackgroundTranscription Start Regions in the Human Genome Are Favored Targets for MLV Integration
Wu, X., Li, Y., Crise, B., & Burgess, S. M. (2003) · Science · doi:10.1126/science.1083413 · Cited by 1,305 · cited 3×
“show a preference for integration near gene 59 ends and CpG islands [13–15].”
BackgroundInfluentialActive genes dynamically colocalize to shared sites of ongoing transcription
Osborne, C. S., Chakalova, L., Brown, K. E., Carter, D., Horton, A., Debrand, E., Goyenechea, B., Mitchell, J. A., Lopes, S., Reik, W., et al. (2004) · Nature Genetics · doi:10.1038/ng1423 · Cited by 1,056
Retroviral DNA Integration: ASLV, HIV, and MLV Show Distinct Target Site Preferences
Mitchell, R. S., Beitzel, B. F., Schroder, A. R. W., Shinn, P., Chen, H., Berry, C. C., Ecker, J. R., & Bushman, F. D. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020234 · Cited by 976
Self-citationGlobal Analysis of Host-Pathogen Interactions that Regulate Early-Stage HIV-1 Replication
König, R., Zhou, Y., Elleder, D., Diamond, T. L., Bonamy, G. M. C., Irelan, J. T., Chiang, C.-Y., Tu, B. P., De Jesus, P. D., Lilley, C. E., et al. (2008) · Cell · doi:10.1016/j.cell.2008.07.032 · Cited by 960
Self-citation
Cited by
Items 101–200 of 248
Capsid–host interactions for HIV-1 ingress
Jang, S., & Engelman, A. (2023) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00048-22 · Cited by 42
Strategies for Targeting Retroviral Integration for Safer Gene Therapy: Advances and Challenges
Yoder, K. E., Rabe, A. J., Fishel, R. A., & Larue, R. C. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.662331 · Cited by 41
Houwer, S. D., Demeulemeester, J., Thys, W., Rocha, S., Dirix, L., Gijsbers, R., Christ, F., & Debyser, Z. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.533281 · Cited by 39
Integration of retroviral vectors
Gabriel, R., Schmidt, M., & Kalle, C. V. (2012) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.08.006 · Cited by 39
Cellular Cofactors of Lentiviral Integrase: From Target Validation to Drug Discovery
Taltynov, O., Desimmie, B. A., Demeulemeester, J., Christ, F., & Debyser, Z. (2012) · Molecular Biology International · doi:10.1155/2012/863405 · Cited by 37
Sites of retroviral DNA integration: From basic research to clinical applications
Serrao, E., & Engelman, A. (2015) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2015.1102859 · Cited by 36
D’Urbano, V., Crignis, E. D., & Re, M. C. (2018) · Current HIV Research · doi:10.2174/1570162x16666180817115830 · Cited by 36
The Nuclear Pore Complex Is a Key Target of Viral Proteases to Promote Viral Replication
Jesús‐González, L. A. D., Palacios-Rápalo, S. N., Reyes-Ruíz, J. M., Osuna‐Ramos, J. F., Cordero‐Rivera, C. D., Farfán-Morales, C. N., Gutiérrez‐Escolano, A. L., & del Ángel, R. M. (2021) · Viruses · doi:10.3390/v13040706 · Cited by 36
Inhibition of Retroviral Replication by Members of the TRIM Protein Family
Fletcher, A. J., & Towers, G. J. (2013) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-37765-5_2 · Cited by 36
Self-citationHeterogeneous susceptibility of circulating SIV isolate capsids to HIV-interacting factors
Mamede, J. I., Sitbon, M., Battini, J., & Courgnaud, V. (2013) · Retrovirology · doi:10.1186/1742-4690-10-77 · Cited by 35
HIV-1 capsid and viral DNA integration
Dwivedi, R., Prakash, P., Kumbhar, B. V., Balasubramaniam, M., & Dash, C. (2023) · mBio · doi:10.1128/mbio.00212-22 · Cited by 34
Interferon-Inducible MicroRNA miR-128 Modulates HIV-1 Replication by Targeting TNPO3 mRNA
Bochnakian, A., Zhen, A., Zisoulis, D. G., Idica, A., KewalRamani, V. N., Neel, N. C., Daugaard, I., Hamdorf, M., Kitchen, S. G., Lee, K., et al. (2019) · Journal of Virology · doi:10.1128/jvi.00364-19 · Cited by 34
Houwer, S. D., Demeulemeester, J., Thys, W., Taltynov, O., Zmajkovicova, K., Christ, F., & Debyser, Z. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.387944 · Cited by 34
Brady, T., Kelly, B. J., Male, F., Roth, S. L., Bailey, A., Malani, N., Gijsbers, R., O’Doherty, U., & Bushman, F. D. (2013) · Journal of Virological Methods · doi:10.1016/j.jviromet.2013.01.004 · Cited by 34
Self-citationHIV-1 Capsid Core: A Bullet to the Heart of the Target Cell
Toccafondi, E., Lener, D., & Negroni, M. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.652486 · Cited by 33
Impact of LEDGIN treatment during virus production on residual HIV-1 transcription
Vansant, G., Vranckx, L. S., Zurnic, I., Looveren, D. V., de Velde, P. V., Nobles, C. L., Gijsbers, R., Christ, F., & Debyser, Z. (2019) · Retrovirology · doi:10.1186/s12977-019-0472-3 · Cited by 33
Recent strategies and progress in identifying host factors involved in virus replication
König, R., & Stertz, S. (2015) · Current Opinion in Microbiology · doi:10.1016/j.mib.2015.06.001 · Cited by 33
Self-citationMullins, J. I., & Frenkel, L. M. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw636 · Cited by 30
TOX4 and NOVA1 Proteins Are Partners of the LEDGF PWWP Domain and Affect HIV-1 Replication
Morchikh, M., Naughtin, M., Nunzio, F. D., Xavier, J., Charneau, P., Jacob, Y., & Lavigne, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081217 · Cited by 29
Engineering Next-Generation BET-Independent MLV Vectors for Safer Gene Therapy
Ashkar, S. E., Looveren, D. V., Schenk, F., Vranckx, L. S., Demeulemeester, J., Rijck, J. D., Debyser, Z., Modlich, U., & Gijsbers, R. (2017) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2017.04.002 · Cited by 28
Meyerson, N. R., Warren, C. J., Vieira, D. A. S. A., Diaz-Griferro, F., & Sawyer, S. L. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1006906 · Cited by 28
Digoxin reveals a functional connection between HIV-1 integration preference and T-cell activation
Zhyvoloup, A., Melamed, A., Anderson, I., Planas, D., Lee, C.-H., Kriston-Vizi, J., Ketteler, R., Merritt, A. T., Routy, J., Ancuța, P., et al. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006460 · Cited by 28
Ciuffi, A. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.02.013 · Cited by 27
Anderson-Daniels, J., Singh, P. K., Sowd, G. A., Li, W., Engelman, A. N., & Aiken, C. (2019) · Journal of Virology · doi:10.1128/jvi.01118-19 · Cited by 23
Toward a Macaque Model of HIV-1 Infection: Roadblocks, Progress, and Future Strategies
Thippeshappa, R., Kimata, J. T., & Kaushal, D. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00882 · Cited by 26
Mamede, J. I., Damond, F., de Bernardo, A., Matheron, S., Descamps, D., Battini, J., Sitbon, M., & Courgnaud, V. (2017) · Scientific Reports · doi:10.1038/srep45214 · Cited by 25
Üstek, D., Sırma, S., Gümüş, E., Arıkan, M., Çakiris, A., Abacı, N., Mathew, J., Emrence, Z., Azaklı, H., Coşan, F., et al. (2012) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2012.05.001 · Cited by 25
Functional analysis of the secondary HIV-1 capsid binding site in the host protein cyclophilin A
Peng, W., Shi, J., Márquez, C. L., Lau, D., Walsh, J. C., Faysal, K. M. R., Byeon, C., Byeon, I. L., Aiken, C., & Böcking, T. (2019) · Retrovirology · doi:10.1186/s12977-019-0471-4 · Cited by 25
Integration Site and Clonal Expansion in Human Chronic Retroviral Infection and Gene Therapy
Niederer, H. A., & Bangham, C. R. M. (2014) · Viruses · doi:10.3390/v6114140 · Cited by 24
The Multifaceted Contributions of Chromatin to HIV-1 Integration, Transcription, and Latency
Crignis, E. D., & Mahmoudi, T. (2016) · International review of cytology · doi:10.1016/bs.ircmb.2016.08.006 · Cited by 24
Impact of Chromatin on HIV Replication
Agosto, L. M., Gagné, M., & Henderson, A. J. (2015) · Genes · doi:10.3390/genes6040957 · Cited by 24
Vranckx, L. S., Demeulemeester, J., Debyser, Z., & Gijsbers, R. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164167 · Cited by 24
The Role of Capsid in the Early Steps of HIV-1 Infection: New Insights into the Core of the Matter
AlBurtamani, N., Paul, A., & Fassati, A. (2021) · Viruses · doi:10.3390/v13061161 · Cited by 23
Ambrosi, A., Glad, I. K., Pellin, D., Cattoglio, C., Mavilio, F., Serio, C. D., & Frigessi, A. (2011) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002292 · Cited by 22
Eschbach, J. E., Elliott, J. L., Li, W., Zadrozny, K. K., Davis, K., Mohammed, S. J., Lawson, D. Q., Pornillos, O., Engelman, A., & Kutluay, S. B. (2020) · Journal of Virology · doi:10.1128/jvi.00984-20 · Cited by 22
The Role of TNPO3 in HIV-1 Replication
Diaz‐Griffero, F. (2012) · Molecular Biology International · doi:10.1155/2012/868597 · Cited by 21
Emerging role of cyclophilin A in HIV-1 infection: from producer cell to the target cell nucleus
Padron, A., Prakash, P., Pandhare, J., Luban, J., Aiken, C., Balasubramaniam, M., & Dash, C. (2023) · Journal of Virology · doi:10.1128/jvi.00732-23 · Cited by 20
Interaction of vectors and parental viruses with the host genome
Gil-Fariña, I., & Schmidt, M. (2016) · Current Opinion in Virology · doi:10.1016/j.coviro.2016.07.004 · Cited by 19
The transmembrane nucleoporin Pom121 ensures efficient HIV-1 pre-integration complex nuclear import
Guo, J., Liu, X., Wu, C., Hu, J., Peng, K., Wu, L. J., Xiong, S., & Dong, C. (2018) · Virology · doi:10.1016/j.virol.2018.06.008 · Cited by 19
Y-box-binding protein 1 supports the early and late steps of HIV replication
Weydert, C., van Heertum, B., Dirix, L., Houwer, S. D., Wit, F. D., Mast, J., Husson, S. J., Busschots, K., König, R., Gijsbers, R., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0200080 · Cited by 19
Self-citationMxB sensitivity of HIV-1 is determined by a highly variable and dynamic capsid surface
Miles, R. J., Kerridge, C., Hilditch, L., Monit, C., Jacques, D. A., & Towers, G. J. (2020) · eLife · doi:10.7554/elife.56910 · Cited by 19
Self-citationBiard‐Piechaczyk, M., Borel, S., Espert, L., de Bettignies, G., & Coux, O. (2011) · Biology of the Cell · doi:10.1111/boc.201100112 · Cited by 19
Sowd, G. A., Shi, J., Fulmer, A. N., & Aiken, C. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011423 · Cited by 18
Zheng, Y., Jayappa, K. D., Ao, Z., Qiu, X., Su, R., & Yao, X. (2019) · Virology Journal · doi:10.1186/s12985-019-1134-8 · Cited by 18
Chaudhuri, E., Dash, S., Balasubramaniam, M., Padron, A., Holland, J., Sowd, G. A., Villalta, F., Engelman, A., Pandhare, J., & Dash, C. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010534 · Cited by 18
Towards a Functional Cure of HIV-1: Insight Into the Chromatin Landscape of the Provirus
Janssens, J., Bruggemans, A., Christ, F., & Debyser, Z. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.636642 · Cited by 18
Santos, M. F., Rappa, G., Karbanová, J., Diana, P., Cirrincione, G., Carbone, D., Manna, D., Aalam, F., Wang, D., Vanier, C. H., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40227-8 · Cited by 18
Retroviral integration profiles: their determinants and implications for gene therapy
Lim, K. (2012) · BMB Reports · doi:10.5483/bmbrep.2012.45.4.207 · Cited by 17
N-terminally truncated POM121C inhibits HIV-1 replication
Saito, H., Takeuchi, H., Masuda, T., Noda, T., & Yamaoka, S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182434 · Cited by 17
N-terminal half of transportin SR2 interacts with HIV integrase
Tsirkone, V. G., Blokken, J., Wit, F. D., Breemans, J., Houwer, S. D., Debyser, Z., Christ, F., & Strelkov, S. V. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.777029 · Cited by 16
Interaction of Transportin-SR2 with Ras-related Nuclear Protein (Ran) GTPase
Taltynov, O., Demeulemeester, J., Christ, F., Houwer, S. D., Tsirkone, V. G., Gérard, M., Weeks, S. D., Strelkov, S. V., & Debyser, Z. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.484345 · Cited by 16
Saeed, M. Q., Dufour, N., Bartholmae, C., Sieranska, U., Knopf, M., Thierry, E., Thierry, S., Delelis, O., Grandchamp, N., Pilet, H., et al. (2014) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2014.65 · Cited by 16
Kleinpeter, A. B., Mallery, D. L., Renner, N., Albecka, A., Klarhof, J. O., Freed, E. O., & James, L. C. (2024) · Nature Communications · doi:10.1038/s41467-024-51971-w · Cited by 15
Self-citationSarkar, S., Balakrishnan, K., Chintala, K., Mohareer, K., Luedde, T., Vasudevan, A. A. J., Münk, C., & Banerjee, S. (2022) · Viruses · doi:10.3390/v14112503 · Cited by 15
Tolomeo, M., Tolomeo, F., & Cascio, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073184 · Cited by 14
Bioinformatics and HIV Latency
Ciuffi, A., Mohammadi, P., Golumbeanu, M., di Iulio, J., & Telenti, A. (2015) · Current HIV/AIDS Reports · doi:10.1007/s11904-014-0240-x · Cited by 14
The Road Less Traveled: HIV's Use of Alternative Routes through Cellular Pathways
Marx, A., & Alian, A. (2015) · Journal of Virology · doi:10.1128/jvi.03684-14 · Cited by 13
Virus–Host Interactions in Retrovirus Integration
Engelman, A. N., & Maertens, G. N. (2018) · Retrovirus-Cell Interactions · doi:10.1016/b978-0-12-811185-7.00004-2 · Cited by 12
Role of Transportin-SR2 in HIV-1 Nuclear Import
Tabasi, M., Nombela, I., Janssens, J., Lahousse, A. P., Christ, F., & Debyser, Z. (2021) · Viruses · doi:10.3390/v13050829 · Cited by 11
Fluorescence Microscopy Assay to Measure HIV-1 Capsid Uncoating Kinetics in vitro
Márquez, C. L., Lau, D., Walsh, J. C., Faysal, K. M. R., Parker, M. W., Turville, S. G., & Böcking, T. (2019) · BIO-PROTOCOL · doi:10.21769/bioprotoc.3297 · Cited by 11
Dynamics and restriction of murine leukemia virus cores in mitotic and interphase cells
Elis, E., Ehrlich, M., & Bacharach, E. (2015) · Retrovirology · doi:10.1186/s12977-015-0220-2 · Cited by 10
Rice, B. L., Stake, M. S., & Parent, L. J. (2020) · Journal of Virology · doi:10.1128/jvi.00640-20 · Cited by 10
Host Factors in Retroviral Integration and the Selection of Integration Target Sites
Craigie, R., & Bushman, F. D. (2015) · ASM Press eBooks · doi:10.1128/9781555819217.ch45 · Cited by 10
Self-citationThe HIV-1 Capsid: More than Just a Delivery Package
James, L. C. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-14741-9_4 · Cited by 9
Self-citationPellaers, E., Bhat, A., Christ, F., & Debyser, Z. (2022) · Viruses · doi:10.3390/v15010032 · Cited by 8
The HIV-1 Capsid-Targeted Inhibitor GSK878 Alters Selection of Target Sites for HIV DNA Integration
Marquis, K. A., Everett, J. K., Cantu, A., McFarland, A. G., Sherrill-Mix, S. A., Krystal, M., Parcella, K. E., Gillis, E. P., Fridell, R. A., & Bushman, F. D. (2023) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2022.0161 · Cited by 8
Self-citationFunctional constraints on HIV-1 capsid: their impacts on the viral immune escape potency
Takemura, T., & Murakami, T. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00369 · Cited by 8
The Early Bird Catches the Worm - Can Evolution Teach us Lessons in Fighting HIV?
Schaller, T., & Herold, N. (2016) · Current HIV Research · doi:10.2174/1570162x14999160224094914 · Cited by 8
Self-citationBell, J. A., Collon, K. W., Mayfield, C. K., Gallo, M. C., Chang, S. W., Sugiyama, O., Tang, A., Hollis, R. P., Chopra, S., Kohn, D. B., et al. (2023) · Gene Therapy · doi:10.1038/s41434-023-00415-z · Cited by 7
Alternative Splicing Caused by Lentiviral Integration in the Human Genome
Moiani, A., & Mavilio, F. (2012) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-386509-0.00008-9 · Cited by 7
Knockdown of the host cellular protein transportin 3 attenuates prototype foamy virus infection
Ali, M. K., Kim, J., Hamid, F. B., & Shin, C. (2015) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2015.1008973 · Cited by 7
HIV-1 Integration into Chromatin: New Insights and Future Perspectives
Lesbats, P., Lavigne, M., & Parissi, V. (2011) · Future Virology · doi:10.2217/fvl.11.84 · Cited by 7
Röling, M. D., Stoszko, M., & Mahmoudi, T. (2016) · InTech eBooks · doi:10.5772/61948 · Cited by 7
Characterization of two distinct early post-entry blocks to HIV-1 in common marmoset lymphocytes
Pacheco, B., Menéndez‐Arias, L., & Sodroski, J. (2016) · Scientific Reports · doi:10.1038/srep37489 · Cited by 7
CRISPR/Cas9-Induced Mutagenesis Corroborates the Role of Transportin-SR2 in HIV-1 Nuclear Import
Janssens, J., Blokken, J., Lampi, Y., Wit, F. D., Zurnic, I., Nombela, I., de Velde, P. V., Remoortel, B. V., Gijsbers, R., Christ, F., et al. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.01336-21 · Cited by 6
Nuclear restriction of HIV-1 infection by SUN1
Persaud, M., Selyutina, A., Buffone, C., Opp, S., Donahue, D. A., Schwartz, O., & Diaz‐Griffero, F. (2021) · Scientific Reports · doi:10.1038/s41598-021-98541-4 · Cited by 5
Role of Innate Genes in HIV Replication
Schott, K., Rieß, M., & König, R. (2017) · Current topics in microbiology and immunology · doi:10.1007/82_2017_29 · Cited by 5
Self-citationCOP9 signalosome subunit 6 binds and inhibits avian leukosis virus integrase
Wang, Z., Xu, A., Hou, X., Chen, F., Cao, W., Yu, J., Liao, M., & Tang, J. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.09.116 · Cited by 5
Advances in Molecular Retrovirology
Saxena, S. K. (2016) · InTech eBooks · doi:10.5772/60583 · Cited by 5
HIV-1 latency: From acquaintance to confidant
Yang, C., Tong, L., & Xue, J. (2025) · Journal of Virus Eradication · doi:10.1016/j.jve.2025.100597 · Cited by 4
Kishimoto, N., Okano, R., Akita, A., Miura, S., Irie, A., Takamune, N., & Misumi, S. (2021) · Retrovirology · doi:10.1186/s12977-021-00574-0 · Cited by 4
Flick, H., Venbakkam, A., Singh, P. K., Layish, B., Huang, S., Radhakrishnan, R., Kvaratskhelia, M., Engelman, A., & Kane, M. (2025) · mBio · doi:10.1128/mbio.02646-24 · Cited by 4
Nuclear Pore Complexes, Genome Organization and HIV-1 Infection
Nunzio, F. D. (2018) · Springer eBooks · doi:10.1007/978-3-319-71614-5_8 · Cited by 4
HIV-1 Integration Site Determines the Transcriptional Fate and Persistence of Integrated ProvirusesPreprint
Pal, V. K., Danesh, A., Canis, M., Dilling, T. R., Miller, I. G., Huynh, T. T., Copertino, D. C., Barrows, D., Carroll, T., Hatziioannou, T., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.26.696579 · Cited by 3
Koneru, P. C. (2019) · OhioLink ETD Center (Ohio Library and Information Network) · Cited by 2
Latency, Expression and Splicing During Infection With HIV
Sherrill-Mix, S. A. (2015) · ScholarlyCommons (University of Pennsylvania) · Cited by 2
Nunzio, F. D., Danckaert, A., Fricke, T., Perez, P., Fernandez, J., Perret, E., Roux, P., Shorte, S. L., Charneau, P., Diaz‐Griffero, F., et al. (2013) · PLoS ONE · doi:10.1371/annotation/34f46796-5d53-4a23-b3df-b599b0369eb9 · Cited by 2
Poirier, V. (2015) · cIRcle (University of British Columbia) · doi:10.14288/1.0135666 · Cited by 2
Nup153 Unlocks the Nuclear Pore Complex for HIV-1 Nuclear Import in Non-Dividing CellsPreprint
Opp, S., Martínez‐López, A., Fricke, T., Buffone, C., Severgnini, M., Cifola, I., Frabetti, S., Skorupka, K. A., Zadrozny, K. K., Ganser‐Pornillos, B. K., et al. (2018) · SSRN Electronic Journal · doi:10.2139/ssrn.3155897 · Cited by 2
Meyerson, N. R., Warren, C. J., Vieira, D. A. S. A., Diaz‐Griffero, F., & Sawyer, S. L. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1006983 · Cited by 2
Ali, M. K., Hossain, M. A., & Shin, C.-G. (2013) · Genes & Genomics · doi:10.1007/s13258-013-0102-8 · Cited by 1
Nucleoporins in Retroviral Replication
Monette, A., & Mouland, A. J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811185-7.00003-0 · Cited by 1
Retroviral Vectors for Gene Therapy of Monogenic Diseases
Yoder, K. E., Rabe, A. J., & Larue, R. C. (2022) · Springer eBooks · doi:10.1007/978-3-030-93333-3_7 · Cited by 1
The functional interplay between TNPO3, CPSF6 and HIV-1 CA
Öztop, I. (2014) · Digital Access to Scholarship at Harvard (DASH) (Harvard University) · Cited by 1
Role of Transportin-SR2 (Transportin-3, TRN-SR2, TNPO3) in HIV Replication
Christ, F., & Debyser, Z. (2018) · Springer eBooks · doi:10.1007/978-1-4939-7101-5_84 · Cited by 1
Transposons: Molecular tools for genome investigation
Patterson, K. (2016) · eScholarship (California Digital Library) · Cited by 1
Structures and functions of the C-Terminal domain of HIV-1 integration
Oladosu, O. (2017) · theses.fr (ABES) · doi:10.70675/ad8059d5z788dz4aafza31dz85b0c784be62 · Cited by 1
Shah, V. B., & Aiken, C. (2013) · Springer eBooks · doi:10.1007/978-1-4614-9610-6_67-1 · Cited by 1
Identification of specific phylogenetic properties of HIV-1 M and O integrases
Toccafondi, E. (2022) · theses.fr (ABES) · doi:10.70675/2facab6ezc20az472dz8350z9fb6e718e1d4 · Cited by 1
Madlala, P. (2011) · ResearchSpace (University of KwaZulu-Natal)
Metadata
- Authors
- Ocwieja, K. E., Brady, T. L., Ronen, K., Huegel, A., Roth, S. L., Schaller, T., James, L. C., Towers, G. J., Young, J. A. T., Chanda, S. K., König, R., Malani, N., Berry, C. C., & Bushman, F. D.
- Affiliations
- University of Pennsylvania (US)
- University College London (GB)
- MRC Laboratory of Molecular Biology (GB)
- Salk Institute for Biological Studies (US)
- Sanford Burnham Prebys Medical Discovery Institute (US)
- University of California San Diego (US)
- Corresponding author
- Bushman, Frederic D.
- ORCID
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-03-10
- Volume
- 7
- Issue
- 3
- Pages
- e1001313
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC3053352
- OpenAlex
- W2158419452
- Cited by
- 212
- References
- 60
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 1 · 2023: 7 · 2022: 4 · 2021: 13 · 2020: 13 · 2019: 16 · 2018: 22 · 2017: 13 · 2016: 18 · 2015: 13 · 2014: 16 · 2013: 30 · 2012: 28
- FWCI
- 11.00
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- UCL Discovery (University College London) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Figshare (submittedVersion, cc-by)
- Funders
- Pennsylvania Department of Health
- Leukemia and Lymphoma Society
- University of Pennsylvania
- Wellcome Trust (WT076608, 090940)
- University College London Hospitals NHS Foundation Trust
- National Institutes of Health
- Center for AIDS Research, University of Washington
- Medical Research Council
- National Institute of Allergy and Infectious Diseases (P01AI090935, AI52845, T32 AI-07324-17, T32AI007324, R01AI082020, R01AI052845, AI082020)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Structure and Function
- Keywords
- TNPO3, RanBP2, Nup358, nucleoporins, karyopherins, HIV Gag, nuclear transport
- MeSH terms
- HIV, Humans, Virus Replication, Gene Expression Regulation, Viral, Molecular Chaperones, Nuclear Pore Complex Proteins, beta Karyopherins, RNA, Small Interfering, gag Gene Products, Human Immunodeficiency Virus, Host-Pathogen Interactions, Gene Knockdown Techniques, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.